Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 05, 2021

SELL
$59.18 - $69.99 $114,158 - $135,010
-1,929 Closed
0 $0
Q1 2021

May 07, 2021

SELL
$59.31 - $78.82 $33,925 - $45,085
-572 Reduced 22.87%
1,929 $122,000
Q4 2020

Jan 13, 2021

SELL
$50.47 - $66.26 $100 - $132
-2 Reduced 0.08%
2,501 $150,000
Q3 2020

Nov 12, 2020

BUY
$51.97 - $63.0 $10,653 - $12,915
205 Added 8.92%
2,503 $150,000
Q2 2020

Aug 13, 2020

SELL
$30.8 - $52.47 $20,235 - $34,472
-657 Reduced 22.23%
2,298 $121,000
Q1 2020

May 12, 2020

BUY
$28.4 - $50.7 $83,609 - $149,260
2,944 Added 26763.64%
2,955 $99,000
Q4 2019

Feb 07, 2020

SELL
$36.31 - $46.83 $726 - $936
-20 Reduced 64.52%
11 $0
Q3 2019

Nov 14, 2019

BUY
$35.66 - $44.99 $1,105 - $1,394
31 New
31 $1,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $763M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Sowell Financial Services LLC Portfolio

Follow Sowell Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sowell Financial Services LLC with notifications on news.